Volume 125, Issue 4, Pages (October 2003)

Slides:



Advertisements
Similar presentations
“Sprue” is a somewhat antiquated term referring generally to intestinal malabsorption.
Advertisements

WHAT IS GLUTEN?. Quick Bread Notes Gluten - a substance present in cereal grains, esp. wheat, that is responsible for the elastic texture of dough; it.
Donald D. Kasarda, Ph.D. Research Chemist (Retired)/Collaborator U.S. Department of Agriculture Agricultural Research Service Western Regional Research.
Simple and complex proteins,. multiprotein complex A multiprotein complex (or protein complex) is a group of two or more associated polypeptide chains.
Biased T Cell Receptor Usage Directed against Human Leukocyte Antigen DQ8- Restricted Gliadin Peptides Is Associated with Celiac Disease Sophie E. Broughton,
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro
Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Celiac Disease: Advances in Treatment via Gluten Modification
Volume 13, Pages (November 2016)
The Gluten-Free Diet: Recognizing Fact, Fiction, and Fad
Volume 129, Issue 3, Pages (September 2005)
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Volume 133, Issue 2, Pages (August 2007)
From: Treatment of Refractory Whipple Disease with Interferon-γ
Current concepts of celiac disease pathogenesis
Volume 151, Issue 4, Pages (October 2016)
Gluten and Celiac Disease
Volume 27, Issue 1, Pages (July 2007)
Nonceliac Gluten Sensitivity: What Is the Culprit?
Volume 128, Issue 2, Pages (February 2005)
Overview and pathogenesis of celiac disease
Enzyme-modified wheat gliadin activates T cells in celiac disease
Volume 149, Issue 6, Pages e2 (November 2015)
Patients With Celiac Disease Have an Increased Risk for Pancreatitis
Volume 154, Issue 4, Pages e6 (March 2018)
Celiac Disease Genetics: Current Concepts and Practical Applications
Antibody Concentrations Decrease 14-Fold in Children With Celiac Disease on a Gluten-Free Diet but Remain High at 3 Months  David Petroff, Johannes Wolf,
Volume 131, Issue 2, Pages (August 2006)
Volume 132, Issue 2, Pages (February 2007)
(A) NK cell cytotoxicity assays against K562, H9, and Raji target cell lines in the presence (black) and absence (white) of an anti-NKp30 antibody, clone.
Volume 137, Issue 2, Pages (August 2009)
Celiac Disease: Advances in Treatment via Gluten Modification
Turning Swords Into Plowshares: Transglutaminase to Detoxify Gluten
Volume 133, Issue 2, Pages (August 2007)
Gliadin Does Not Induce Mucosal Inflammation or Basophil Activation in Patients With Nonceliac Gluten Sensitivity  Cristina Bucci, Fabiana Zingone, Ilaria.
Ira J. Fox, Stephen C. Strom  Gastroenterology 
T-Cell Response to Gluten in Patients With HLA-DQ2
Volume 115, Issue 3, Pages (September 1998)
Volume 133, Issue 3, Pages (September 2007)
Spreading and focusing of gluten epitopes in celiac disease
Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease  Avital.
Volume 132, Issue 4, Pages (April 2007)
Volume 27, Issue 1, Pages (July 2007)
Enzyme-modified wheat gliadin activates T cells in celiac disease
Current concepts of celiac disease pathogenesis
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 151, Issue 4, Pages (October 2016)
Shadi Rashtak, Michael W. Ettore, Henry A. Homburger, Joseph A. Murray 
Volume 123, Issue 3, Pages (September 2002)
Volume 37, Issue 4, Pages (October 2012)
Volume 128, Issue 2, Pages (February 2005)
Severe Constipation Clinical Gastroenterology and Hepatology
Volume 124, Issue 7, Pages (June 2003)
Celiac Disease: From Pathogenesis to Novel Therapies
Volume 24, Issue 10, Pages (October 2016)
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Volume 147, Issue 4, Pages e8 (October 2014)
Celiac Disease: Caught Between a Rock and a Hard Place
Volume 153, Issue 3, Pages e4 (September 2017)
Volume 37, Issue 4, Pages (October 2012)
Volume 36, Issue 1, Pages (January 2012)
Volume 122, Issue 7, Pages (June 2002)
Michelle Maria Pietzak  Gastroenterology 
Volume 129, Issue 3, Pages (September 2005)
Volume 133, Issue 3, Pages (September 2007)
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Volume 115, Issue 3, Pages (September 1998)
Volume 15, Issue 3, Pages (September 2001)
Presentation transcript:

Volume 125, Issue 4, Pages 1105-1113 (October 2003) Characterization of cereal toxicity for celiac disease patients based on protein homology in grains 1   L.Willemijn Vader, Dariusz T Stepniak, Evelien M Bunnik, Yvonne M.C Kooy, Willeke De Haan, Jan Wouter Drijfhout, Peter A Van Veelen, Frits Koning  Gastroenterology  Volume 125, Issue 4, Pages 1105-1113 (October 2003) DOI: 10.1016/S0016-5085(03)01204-6

Figure 1 Alignments of gliadin, secalin, and hordein proteins. (A) The presence and location of the glia-α9 peptides in gliadin molecules. The accession numbers of the represented gliadin molecules are gda0_wheat (P02863), Gda2_ wheat (P04722), Gda4_wheat (P04724), and Gda9_wheat (P18573). (B) The presence and location of gliadin homologues in secalins and hordeins. The glia-γ2 epitope present in γ-gliadin (P06659), secalin (S18236), and hordein (P17990) aligns in the same region in these proteins. Moreover, a secalin homologue of the glia-γ1 epitope is present at the same relative position. (C) Clustered glia-α2 and glia-α9 homologues are present at the N-terminus of a secalin molecule (A23277). ∗A glia-γ2 homologue that is equally recognized by gluten-specific T cells.2 Gastroenterology 2003 125, 1105-1113DOI: (10.1016/S0016-5085(03)01204-6)

Figure 2 Stimulation of gluten-specific T cells by hordein, secalin, and avenin peptides. (A) and (C) Proliferative response of polyclonal T-cell lines derived from 2 patients with celiac disease against hordein, secalin, and avenin peptides. (B) Interferon gamma production by a T-cell line from patient 1. (D) Proliferative response of T-cell clones derived from 2 other patients with celiac disease against hordein, secalin, and avenin peptides. Gastroenterology 2003 125, 1105-1113DOI: (10.1016/S0016-5085(03)01204-6)

Figure 3 Stimulation of gluten-specific T cells by modified gluten epitopes. Stimulation of T-cell clones (A) NV17 and (B) Sim156 by the glutenin-17 epitope (QQPPFSQQQQPVLPQ), a natural homologue (QQPPFSQQQQLVLPQ), and 2 modified variant peptides (QQPPFSEQEQLVLPQ and QQPPFSEE EEPVLPQ). Deamidation of the glutamine residues in the peptides by tTG is indicated with an underlined Q. Gastroenterology 2003 125, 1105-1113DOI: (10.1016/S0016-5085(03)01204-6)

Figure 4 Stimulation of gluten-specific T-cell clones with gluten homologue peptides. (A-C) Stimulation of T-cell clones NB10, L6, and L9, respectively, by the deamidated glia-α9 epitope (QLQPFPQPELPY) and variant peptides both before and after treatment with tTG. Deamidation of the glutamine residues in the peptides by tTG is indicated with an underlined Q. Gastroenterology 2003 125, 1105-1113DOI: (10.1016/S0016-5085(03)01204-6)